Journal of Diagnostics Concepts & Practice >
Study on human papillomavirus infection in gynecological outpatients in Songjiang District during 2016 to 2017
Received date: 2019-06-01
Online published: 2019-08-25
Objective: To analyze the distribution of human papilloma virus (HPV) infection and subtypes in Songjiang District, Shanghai for providing a theoretical basis for prevention of HPV infection. Method: A total of 52 973 gynecological outpatients tested for HPV subtypes by gene chip detection were enrolled in this study. Result: A total of 12 139 patients were infected with HPV. The HBV infection rate was 22.92%. Altogether 16 637 strains of human papilloma virus were detected, and high-risk HPV subtypes accounted for 78.61%. The top five infection subtypes were: HPV16, 58, 52, 51, 68, all of which were high-risk subtypes. Of the infected patients, 8 933 cases were single infection (73.50%), mainly with high-risk subtypes, accounting for 80.48%; 3 206 cases were multiple infection (26.50%), most of which were double infection with high-risk subtype (57.71%), and the common ones were HPV16 and 58. The infection rates of ≤20 years old, 21-30 years old, 31-40 years old, 41-50 years old, 51-60 years old, ≥61 years old groups were 31.83%, 21.48%, 20.66%, 23.69%, 30.35%, 33.88%, respectively. Conclusions: In Songjiang District, HPV infection rate among gynecological outpatients was 22.92%. The most common HPV subtypes were 16, 58, 52, 51, 68. The majority is single infection, and most of which with high-risk subtypes. Among double infection, most were high-risk subtype combination. The age group ≥60 years shows higher infection rate.
Key words: Human papillomavirus (HPV); Subtype; Infection
WANG HONG, HUANG Luyao, YANG Yixiang . Study on human papillomavirus infection in gynecological outpatients in Songjiang District during 2016 to 2017[J]. Journal of Diagnostics Concepts & Practice, 2019 , 18(04) : 460 -465 . DOI: 10.16150/j.1671-2870.2019.04.015
[1] | Vaezi T, Shoja Z, Hamkar R, et al. Human papillomavirus type 16 lineage analysis based on E6 region in cervical samples of Iranian women[J]. Infect Genet Evol, 2017, 55:26-30. |
[2] | Chen W, Zheng R, Baade PD, et al. Cancer statistics in China,2015[J]. CA Cancer J Clin, 2016, 66(2):115-132. |
[3] | Schiffman M, Castle PE, Jeronimo J, et al. Human papillomavirus and cervical cancer[J]. Lancet, 2007, 370(9590): 890-907. |
[4] | Zandberg DP, Bhargava R, Badin S, et al. The role of human papillomavirus in nongenital cancers[J]. CA Cancer J Clin, 2013, 63(1):57-81. |
[5] | Choi YJ, Park JS. Clinical significance of human papillomavirus genotyping[J]. J Gynecol Oncol, 2016, 27(2):e21. |
[6] | 王蕾, 董志玲, 张利宾, 等. 邯郸地区10 306例妇科门诊女性患者HPV基因分型及感染特征分析[J]. 医学综述, 2019, 25(6):1245-1248. |
[7] | 杨阳, 陈良远, 曹鹏驹, 等. 福州地区体检女性HPV感染及基因亚型分析[J]. 检验医学, 2019, 34(2):144-147. |
[8] | 温旺荣, 李莉. HPV 基因检测技术新进展[J]. 中华检验医学杂志, 2015, 38(8):514-516. |
[9] | 许惠惠, 石卫武, 徐玖飞, 等. HPV 基因分型在宫颈癌筛查风险分层管理中的价值[J]. 中华实验和临床病毒学杂志, 2016, 30(1):14-18. |
[10] | 单玮, 张涛, 张铁军, 等. 我国女性人乳头瘤病毒(HPV)感染的流行病学现状[J]. 中华疾病控制杂志, 2017, 21(1):89-93. |
[11] | 李栋立, 秦基取, 钱福初, 等. 浙江省湖州地区10 680例女性人乳头瘤病毒感染及基因分型分析[J]. 疾病监测, 2015, 30(3):209-213. |
[12] | 冀静, 张海满, 李娜, 等. 西安地区门诊机会筛查妇女HPV感染状况分析[J]. 海南医学, 2017, 28(18):3004-3006. |
[13] | 许维东, 李月, 滕贤麟, 等. 浙江省金华市人民医院妇科门诊女性感染宫颈上皮细胞人乳头瘤病毒亚型分布特征分析[J]. 中国基层医药, 2017, 24(8):1225-1228. |
[14] | Wen Z, Lei Z, Jin-An M, et al. The inhibitory role of miR-214 in cervical cancer cells through directly targe-ting mitochondrial transcription factor A (TFAM)[J]. Eur J Gynaecol Oncol, 2014, 35(6):676-682. |
[15] | Singh S, Zhou Q, Yu Y, et al. Distribution of HPV genotypes in Shanghai women[J]. Int J Clin Exp Pathol, 2015, 8(9):11901-11908. |
[16] | 吴翠霞, 张艳红, 葛小花, 等. 高危型HPV感染与宫颈癌前病变与宫颈癌的相关性研究[J]. 中华医院感染学杂志, 2016, 26(11):2568-2570. |
[17] | de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study[J]. Lancet Oncol, 2010, 11(11):1048-1056. |
[18] | Lehtinen M, Paavonen J, Wheeler CM, et al. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial[J]. Lancet Oncol, 2012, 13(1):89-99. |
[19] | 缪应新, 甘洁民, 陈洁, 等. 上海地区人乳头瘤病毒基因芯片法分型检测的临床意义[J]. 检验医学, 2015, 30(6):595-598. |
/
〈 |
|
〉 |